Urakawa, R.; Isomura, E.T.; Matsunaga, K.; Kubota, K.
Young Age, Female Sex, and No Comorbidities Are Risk Factors for Adverse Reactions after the Third Dose of BNT162b2 COVID-19 Vaccine against SARS-CoV-2: A Prospective Cohort Study in Japan. Vaccines 2022, 10, 1357.
https://doi.org/10.3390/vaccines10081357
AMA Style
Urakawa R, Isomura ET, Matsunaga K, Kubota K.
Young Age, Female Sex, and No Comorbidities Are Risk Factors for Adverse Reactions after the Third Dose of BNT162b2 COVID-19 Vaccine against SARS-CoV-2: A Prospective Cohort Study in Japan. Vaccines. 2022; 10(8):1357.
https://doi.org/10.3390/vaccines10081357
Chicago/Turabian Style
Urakawa, Ryuta, Emiko Tanaka Isomura, Kazuhide Matsunaga, and Kazumi Kubota.
2022. "Young Age, Female Sex, and No Comorbidities Are Risk Factors for Adverse Reactions after the Third Dose of BNT162b2 COVID-19 Vaccine against SARS-CoV-2: A Prospective Cohort Study in Japan" Vaccines 10, no. 8: 1357.
https://doi.org/10.3390/vaccines10081357
APA Style
Urakawa, R., Isomura, E. T., Matsunaga, K., & Kubota, K.
(2022). Young Age, Female Sex, and No Comorbidities Are Risk Factors for Adverse Reactions after the Third Dose of BNT162b2 COVID-19 Vaccine against SARS-CoV-2: A Prospective Cohort Study in Japan. Vaccines, 10(8), 1357.
https://doi.org/10.3390/vaccines10081357